A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 91
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VMAT
Long Form : vesicular monoamine transporter
No. Year Title Co-occurring Abbreviation
2021 Genetic or Toxicant-Induced Disruption of Vesicular Monoamine Storage and Global Metabolic Profiling in Caenorhabditis elegans. VMAT2
2021 Sex differences in the transcription of monoamine transporters in major depression. DAT, DLPFC, MDD, NET, PMAT, SERT, TPH
2021 The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease. ALDH, DOPAL, PD
2021 Tyramine synthesis, vesicular packaging, and the SNARE complex function coordinately in astrocytes to regulate Drosophila alcohol sedation. Tdc2
2020 Characteristic of Dopamine-Producing System and Dopamine Receptors in the Suprachiasmatic Nucleus in Rats in Ontogenesis. AADC, DA, SCN, TH
2020 Differences in the expression of catecholamine-synthesizing enzymes between vesicular monoamine transporter 1- and 2-immunoreactive glomus cells in the rat carotid body. CB
2020 Identification and characterisation of serotonin signalling in the potato cyst nematode Globodera pallida reveals new targets for crop protection. ---
2019 Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors. DR, TH, Treg
2019 Drosophila Ptp4E regulates vesicular packaging for monoamine-neuropeptide co-transmission. DCVs, RPTP
10  2019 LOVIT Is a Putative Vesicular Histamine Transporter Required in Drosophila for Vision. LOVIT
11  2019 The catecholaldehyde hypothesis: where MAO fits in. ALDH, DOPAC, DOPAL, MAO
12  2018 Perivascular Adipocytes Store Norepinephrine by Vesicular Transport. PVAT
13  2018 Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies. AAPs, TAPs, TD
14  2018 The ins and outs of vesicular monoamine transporters. ---
15  2017 Saikosaponin A Alleviates Symptoms of Attention Deficit Hyperactivity Disorder through Downregulation of DAT and Enhancing BDNF Expression in Spontaneous Hypertensive Rats. ADHD, BDNF, DA, DAT, PFC, SHR, SSa, TH
16  2016 Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis. ---
17  2016 Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain. DAT
18  2015 Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles. APDs, CYAM, D2R, DA, DAT, PCA
19  2015 Behavioral and neurochemical effects induced by reserpine in mice. DAT, MAO, TH, VCMs
20  2015 Dopamine, vesicular transporters, and dopamine receptor expression in rat major salivary glands. NSE
21  2015 Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials. APs, TD
22  2015 Hypothalamic differences in expression of genes involved in monoamine synthesis and signaling pathways after insulin injection in chickens from lines selected for high and low body weight. DEGs, HWS, LWS, SNPs, TH
23  2015 Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. DA, DAT
24  2015 Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease. ALDH, DOPAC, DOPAL, DOPET, PD
25  2014 Functionally important carboxyls in a bacterial homologue of the vesicular monoamine transporter (VMAT). BbMAT
26  2014 Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. DA, PD
27  2014 Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway. DAT
28  2013 Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. DA
29  2013 Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration. DAT, PD
30  2013 Small-molecule screen in adult Drosophila identifies VMAT as a regulator of sleep. ---
31  2013 T-cell subpopulations express a different pattern of dopaminergic markers in intra- and extra-thymic compartments. DAT
32  2012 Dispensable, redundant, complementary, and cooperative roles of dopamine, octopamine, and serotonin in Drosophila melanogaster. dVMAT
33  2012 VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination. KO
34  2011 A microRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons. DA, DAT, hSNCA, PD, SNCA, TH
35  2011 Elevated levels of the vesicular monoamine transporter and a novel repetitive behavior in the Drosophila model of fragile X syndrome. FXS
36  2011 Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas. DA, GEP-NETs, GUS, NAT, PCC, PGL, sst
37  2011 Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells. ATP, bFGF, BM, DA, DARPP, ELISA, En, FGF8, Map2ab, MSC, Nurr1, PTCH, RT, SHH, Smo, TH, WJ
38  2010 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. FDOPA-PET, PGLs, PHEOs
39  2010 Development of pH-responsive fluorescent false neurotransmitters. pH-responsive FFNs
40  2010 Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring. AMP, DA, NAc, PFC, VTA
41  2010 Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles. 293-hNET, NE, NET
42  2010 The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons. dVMAT
43  2010 Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry. ---
44  2009 Activity-dependent vesicular monoamine transporter-mediated depletion of the nucleus supports somatic release by serotonin neurons. ---
45  2009 Reserpine ameliorates Abeta toxicity in the Alzheimer's disease model in Caenorhabditis elegans. AD
46  2008 Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: relevance in selective neuronal vulnerability to degeneration. 3-NT, DA, DAT, PD, VTA, vtSN
47  2008 Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. DA
48  2008 Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen. ---
49  2008 Effect of antrectomy in hypergastrinaemic female Japanese cotton rats. ---
50  2008 Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. ---
51  2008 Polychlorinated biphenyl-induced oxidative stress in organotypic co-cultures: experimental dopamine depletion prevents reductions in GABA. AMPT, DA, NAC, PCBs, VM
52  2008 Trafficking of vesicular neurotransmitter transporters. SVs, VGLUT
53  2008 Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP+ derivatives: a structure-activity study. MPTP
54  2007 Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP. DAT, MPTP, PM, TH
55  2007 Perturbation of dopamine metabolism by 3-amino-2-(4'-halophenyl)propenes leads to increased oxidative stress and apoptotic SH-SY5Y cell death. APP, DA, DbetaM, MAO, ROS
56  2007 The vesicular monoamine transporter 2 contains trafficking signals in both its N-glycosylation and C-terminal domains. LDCVs, SVs, VAChT
57  2007 Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells. ---
58  2007 Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. DA, SWIP
59  2006 Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters. VGAT, VGLUT
60  2006 Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. CPu, METH, PD, pp, SNpc, TH
61  2006 Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2. EMT, OCT2
62  2006 Regulation of vesicular monoamine and glutamate transporters by vesicle-associated trimeric G proteins: new jobs for long-known signal transduction molecules. VGLUT
63  2005 Characterization of bacterial drug antiporters homologous to mammalian neurotransmitter transporters. MFS
64  2005 Choroidal innervation in primate eyes. CGC, NOS, NPY, TH, VAChT, VIP
65  2005 Neuro-immunity in stress-related oral ulcerations: a fractal analysis. OLP, RAS, VAchT
66  2005 Serotonin transporter function is an early step in left-right patterning in chick and frog embryos. SERT
67  2004 Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. 5-HIAA, DA, DOPAC, DTBZ, HPLC, MDMA, PET
68  2004 Immunohistochemical classification and functional morphology of human choroidal ganglion cells. CGCs, CGRP, nNOS, NPY, SP, TH, VAChT, VIP
69  2004 PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content. DA, DAT, DOPAC, PCB
70  2004 Selective alterations of gene expression in mice induced by MPTP. COMT, DA, DAT, MPTP, PD, TH
71  2004 The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. AADC, DA, DOPAC, PD, TH
72  2004 [Genetic models to understand how serotonin acts during development]. SERT, TPH
73  2001 Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours. ---
74  2001 Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. DAT
75  2001 Neuropeptide localization in the "migraine generator" region of the human brainstem. CGRP, CPON, LC, NRM, PACAP, PAG, SP, VIP
76  2001 [Function of monoamine neurotransmitter transporters]. DAT, NET, SERT
77  2000 Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. DAT, IR, METH, PET, TH, VMD
78  2000 Transport mechanisms in acetylcholine and monoamine storage. VAChT
79  1999 Cholinergic, monoaminergic and glutamatergic changes following perinatal asphyxia in the rat. EAAC1, IR, PA, TH, VAChT
80  1999 Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. CAG, CgA, EC, ECL, NEC, ZES
81  1998 Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors. SSTR
82  1997 Effects of nerve growth factor on dihydrotetrabenazine binding to PC12 cells. TBZOH
83  1997 The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules. AZIK
84  1997 Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. ACh, ChAT, VAChT, VAChT
85  1996 Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate. ---
86  1996 Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites. ---
87  1996 Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion. ---
88  1995 Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter. TBZ
89  1994 Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites. TBZ
90  1994 Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. ---
91  1994 Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat. ---